JAMA Surgery : Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS

JAMA Network - Een podcast door The JAMA Network

Probeer Podimo de eerste 30 dagen gratis gratis

Probeer Podimo de eerste 30 dagen gratis gratis

Luister 30 dagen gratis naar exclusieve podcasts en duizenden luisterboeken

 Sponsored

Interview with Seema A. Khan, MD, author of Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial. Hosted by Amalia Cochran, MD. Related Content: Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ

Visit the podcast's native language site